At close: December 23 at 8:08:23 AM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BT3.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 11/20/2024 |
| Initiated | D. Boral Capital: Buy | 11/18/2024 |
| Initiated | Craig-Hallum: Buy | 8/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/8/2024 |
Related Tickers
52U.F Hyloris Pharmaceuticals SA
5.18
-1.15%
BT1.F BioSenic S.A.
0.0123
0.00%
PHGN.BE Pharming Group
0.8715
+2.77%
OVIT OncoVista Innovative Therapies, Inc.
0.0002
0.00%
PHG.F Pharming Group N.V.
8.60
+2.99%
HSTC HST Global, Inc.
0.8300
0.00%
8BT.F BriaCell Therapeutics Corp.
0.4600
-6.12%
CZTA.BE Checkpoint Therapeutics Inc
3.3950
-3.00%
AKBLF ALK-Abelló A/S
22.35
0.00%
OCSAW Oculis Holding AG
5.38
-4.95%